BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3097109)

  • 1. The treatment of mild to severe chronic idiopathic urticaria with astemizole: double-blind and open trials.
    Fox RW; Lockey RF; Bukantz SC; Serbousek D
    J Allergy Clin Immunol; 1986 Dec; 78(6):1159-66. PubMed ID: 3097109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of astemizole, a long-acting and nonsedating H1 antagonist for the treatment of chronic idiopathic urticaria.
    Bernstein IL; Bernstein DI
    J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):37-42. PubMed ID: 3080510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of astemizole and terfenadine in the treatment of chronic idiopathic urticaria. A randomized double-blind study of 40 patients.
    Paul E; Bödeker RH
    Ann Allergy; 1989 Apr; 62(4):318-20. PubMed ID: 2565098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged benefit in the treatment of chronic idiopathic urticaria with astemizole.
    Honsinger RW; Thomsen RJ
    Ann Allergy; 1990 Sep; 65(3):194-200. PubMed ID: 1976298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled clinical assessment of astemizole in the treatment of chronic idiopathic urticaria and angioedema.
    Kailasam V; Mathews KP
    J Am Acad Dermatol; 1987 Apr; 16(4):797-804. PubMed ID: 2883202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of astemizole and terfenadine in the treatment of chronic urticaria. A randomized double-blind study of 40 patients].
    Paul E; Bödeker RH
    Z Hautkr; 1985; 60 Suppl 1():50-5. PubMed ID: 2859714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria.
    Cainelli T; Seidenari S; Valsecchi R; Mosca M
    Pharmatherapeutica; 1986; 4(10):679-86. PubMed ID: 2885854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of chronic idiopathic urticaria with astemizole.
    Huerter CJ; Bergfeld WF; Wagner WO; Dijkstra JW
    Cleve Clin J Med; 1989 May; 56(3):263-6. PubMed ID: 2568189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical profile of astemizole. A survey of 50 double-blind trials.
    Vanden Bussche G; Emanuel MB; Rombaut N
    Ann Allergy; 1987 Mar; 58(3):184-8. PubMed ID: 2881507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cetirizine vs astemizole in the treatment of chronic idiopathic urticaria.
    Alomar A; De La Cuadra ; Fernandez J
    J Int Med Res; 1990; 18(5):358-65. PubMed ID: 2147912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of astemizole and chlorpheniramine in dermographic urticaria.
    Krause LB; Shuster S
    Br J Dermatol; 1985 Apr; 112(4):447-53. PubMed ID: 3922395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetirizine and astemizole therapy for chronic idiopathic urticaria: a double-blind, placebo-controlled, comparative trial.
    Breneman D; Bronsky EA; Bruce S; Kalivas JT; Klein GL; Roth HL; Tharp MD; Treger C; Soter N
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):192-8. PubMed ID: 7622644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study.
    Zuberbier T; Oanta A; Bogacka E; Medina I; Wesel F; Uhl P; Antépara I; Jáuregui I; Valiente R;
    Allergy; 2010 Apr; 65(4):516-28. PubMed ID: 19860762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of H1 antagonists in the treatment of chronic idiopathic urticaria.
    Sussman G; Jancelewicz Z
    Ann Allergy; 1991 Oct; 67(4):433-9. PubMed ID: 1683191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria.
    Breneman DL
    Ann Pharmacother; 1996 Oct; 30(10):1075-9. PubMed ID: 8893110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, multicenter trial.
    Ortonne JP; Grob JJ; Auquier P; Dreyfus I
    Am J Clin Dermatol; 2007; 8(1):37-42. PubMed ID: 17298105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Astemizole in urticaria--a multicenter study by 412 established dermatologists].
    Kurz K; Oestreich W
    Z Hautkr; 1987 Dec; 62(24):1724-32. PubMed ID: 2894098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azelastine tablets in the treatment of chronic idiopathic urticaria. Phase iii, randomised, double-blind, placebo and active controlled multicentric clinical trial.
    Camarasa JM; Aliaga A; Fernández-Vozmediano JM; Fonseca E; Iglesias L; Tagarro I
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):77-86. PubMed ID: 11316966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.